Engineering an Epigenome Editor

a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck’s individualized treatment for melanoma, after more than a decade of work on personalized cancer vaccines. ...  Show more

Julie Yoo sits down with Dr. Suchi Saria, founder and CEO of Bayesian Health, to discuss the current state of clinical AI and what it takes to deploy AI systems in real-world healthcare settings. While much of the recent attention around AI has focused on copilots, chatbots, and ...  Show more

CRISPR has emerged as a powerful tool for altering DNA sequences with incredible precision, opening up new avenues of research into the treatment of disease. In this episode, we explore the science behind CRISPR, as well as its potential. From curing genetic disorders to creating ...  Show more

We look at a gene editing breakthrough, a new technique to correct genetic errors in sick patients. Roland speaks to Professor David Liu to learn about the base editing technology.Also, we look into the complex causes of last year's post-pandemic spike in child hepatitis. Profess ...  Show more

In this edition of Naked Genetics, we take a closer look at CRISPR gene editing. What is it? And what are the ethics involved in rewriting the human genome? Like this podcast? Please help us by supporting the Naked Scientists 

This week, we deep-dive into the world of genome engineering and yeast organisms with Leslie Mitchell. She’s the Co-founder and CEO of Neochromosome, a synthetic biology company specialising in whole chromosome delivery and highly automated synthesis of complex DNA. Leslie, one o ...  Show more